Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter EquipmentCardiovascular Device

PUBLISHER: Grand View Research | PRODUCT CODE: 1726135

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1726135

Transcatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report By Product (Coil, Non-coil),By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Transcatheter Embolization And Occlusion Devices Market Growth & Trends:

The global transcatheter embolization and occlusion devices market size is estimated to reach USD 8.54 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.

In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.

Asia Pacific TEO devices market is anticipated to witness highest CAGR, due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices.

Transcatheter Embolization And Occlusion Devices Market Report Highlights:

  • In 2024, The non-coil product segment dominated the market with the largest revenue share of 52.3%, propelled by its versatility and effectiveness in a wide range of clinical applications.
  • Based product, the coil segment is anticipated to grow at a significant CAGR of 7.0% over the forecast period, driven by its growing application in treating various vascular conditions.
  • North America dominated the global market with the largest revenue share of 36.6% in 2024, attributed to the increased adoption of Interventional Radiology (IR) procedures.
Show more
Product Code: 978-1-68038-670-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional Scope
    • 1.2.3. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Embolization and Occlusion Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Transcatheter Embolization and Occlusion Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Transcatheter Embolization and Occlusion Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
  • 4.3. Global Transcatheter Embolization and Occlusion Devices Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Coil
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Pushable Coils
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Detachable Coils
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Non Coil
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Flow Diverting Devices
      • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Embolization Particles
      • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Liquid Embolics
      • 4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Other Embolization and Occlusion Devices
      • 4.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Accessories
      • 4.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Transcatheter Embolization and Occlusion Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Transcatheter Embolization and Occlusion Devices Market by Region: Key Takeaways
  • 5.4. North America
    • 5.4.1. U.S.
      • 5.4.1.1. Key Country Dynamics
      • 5.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.1.3. Competitive Scenario
      • 5.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Canada
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.2.3. Competitive Scenario
      • 5.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Mexico
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.3.3. Competitive Scenario
      • 5.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. U.K.
      • 5.5.1.1. Key Country Dynamics
      • 5.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.1.3. Competitive Scenario
      • 5.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. France
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Italy
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Spain
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.5.3. Competitive Scenario
      • 5.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Denmark
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.6.3. Competitive Scenario
      • 5.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.7.3. Competitive Scenario
      • 5.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.8. Norway
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.8.3. Competitive Scenario
      • 5.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. China
      • 5.6.1.1. Key Country Dynamics
      • 5.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.1.3. Competitive Scenario
      • 5.6.1.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.3. India
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.4. South Korea
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Australia
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Thailand
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.7.2.3. Competitive Scenario
      • 5.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.7.3.3. Competitive Scenario
      • 5.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Middle East and Africa
    • 5.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.2.3. Competitive Scenario
      • 5.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.3.3. Competitive Scenario
      • 5.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.4.3. Competitive Scenario
      • 5.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.5.3. Competitive Scenario
      • 5.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/ Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key Company Heat Map Analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Boston Scientific Corporation
      • 6.4.1.1. Company Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. Terumo Corporation
      • 6.4.2.1. Company Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Medtronic
      • 6.4.3.1. Company Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. DePuy Synthes (Johnson & Johnson)
      • 6.4.4.1. Company Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Stryker
      • 6.4.5.1. Company Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Cordis
      • 6.4.6.1. Company Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Abbott
      • 6.4.7.1. Company Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Pfizer Inc.
      • 6.4.8.1. Company Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Sirtex SIR-Spheres Pty Ltd.
      • 6.4.9.1. Company Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Nordion (Canada) Inc.
      • 6.4.10.1. Company Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
Show more
Product Code: 978-1-68038-670-7

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Transcatheter Embolization and Occlusion Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 5. North America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 6. North America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 7. U.S. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8. Canada Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 9. Mexico Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 10. Europe Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 11. Europe Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 12. U.K. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13. Germany Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 14. France Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15. Italy Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 16. Spain Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 17. Denmark Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 18. Sweden Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19. Norway Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 20. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 21. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 22. China Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23. Japan Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 24. India Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 25. South Korea Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 26. Australia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27. Thailand Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 28. Latin America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 29. Latin America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 30. Brazil Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 31. Argentina Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 34. South Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 35. Saudi Arabia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 36. UAE Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 37. Kuwait Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Transcatheter Embolization and Occlusion Devices Market: Market Outlook
  • Fig. 10 Transcatheter Embolization and Occlusion Devices Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Transcatheter Embolization and Occlusion Devices Market Driver Impact
  • Fig. 16 Transcatheter Embolization and Occlusion Devices Market Restraint Impact
  • Fig. 17 Transcatheter Embolization and Occlusion Devices Market Strategic Initiatives Analysis
  • Fig. 18 Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
  • Fig. 19 Transcatheter Embolization and Occlusion Devices Market: Product Outlook and Key Takeaways
  • Fig. 20 Coil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Pushable Coils Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Detachable Coils Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Non Coil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Flow Diverting Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Embolization Particles Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid Embolics Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Other Embolization and Occlusion Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Accessories Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Global Transcatheter Embolization and Occlusion Devices Market: Regional Movement Analysis
  • Fig. 30 Global Transcatheter Embolization and Occlusion Devices Market: Regional Outlook and Key Takeaways
  • Fig. 31 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Kuwait Market Estimates and Forecasts, 2018 - 2030
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!